Literature DB >> 8444875

Novel phosphorylation sites of eukaryotic initiation factor-4F and evidence that phosphorylation stabilizes interactions of the p25 and p220 subunits.

X Bu1, D W Haas, C H Hagedorn.   

Abstract

Only serine phosphorylation of eukaryotic initiation factor-4E (eIF-4E) has been previously reported in intact cells. We found that treatment of HepG2 cells with okadaic acid resulted in as much as 20% of eukaryotic initiation factor (eIF)-4E phosphorylation occurring on threonine residues and that tryptic phosphopeptide maps showed several previously unrecognized phosphopeptides. Analysis of p220 from control and okadaic acid-treated cells demonstrated serine and threonine phosphorylation under both conditions. However, a unique pattern of phosphopeptides in okadaic acid-treated cells was observed. The most notable finding was that hyperphosphorylation of eIF-4E and p220 increased binding of p220 but not eIF-4E to the m7GTP cap structure. We suggest that phosphorylation of eIF-4E is more complicated than previously recognized and that hyperphosphorylation of eIF-4E and p220 recruits more p220 into the protein complex that associates with mRNA caps. A better understanding of these protein-protein and protein-mRNA interactions may aid the design of anti-sense directed chemistries that disrupt such interactions for a specific target mRNA (Baker, B.F., Miraglia, L., and Hagedorn, C. H. (1992) J. Biol. Chem. 267, 11495-11499).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8444875

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E.

Authors:  Yikun Li; Ping Yue; Xingming Deng; Takeshi Ueda; Rikiro Fukunaga; Fadlo R Khuri; Shi-Yong Sun
Journal:  Neoplasia       Date:  2010-10       Impact factor: 5.715

Review 2.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

Review 3.  Functional evolution of cyclin-dependent kinases.

Authors:  John H Doonan; Georgios Kitsios
Journal:  Mol Biotechnol       Date:  2009-01-15       Impact factor: 2.695

4.  Upf1 phosphorylation triggers translational repression during nonsense-mediated mRNA decay.

Authors:  Olaf Isken; Yoon Ki Kim; Nao Hosoda; Greg L Mayeur; John W B Hershey; Lynne E Maquat
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582

Review 5.  Molecular mechanisms for the control of translation by insulin.

Authors:  C G Proud; R M Denton
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

6.  Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2.

Authors:  U Knauf; C Tschopp; H Gram
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

7.  Neurotrophin-3 targets the translational initiation machinery in oligodendrocytes.

Authors:  Rochelle P Coelho; Larra M Yuelling; Babette Fuss; Carmen Sato-Bigbee
Journal:  Glia       Date:  2009-12       Impact factor: 7.452

8.  Insulin-stimulated kinase from rat fat cells that phosphorylates initiation factor 4E-binding protein 1 on the rapamycin-insensitive site (serine-111).

Authors:  K J Heesom; M B Avison; T A Diggle; R M Denton
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

9.  Translational regulation during activation of porcine peripheral blood lymphocytes: association and phosphorylation of the alpha and gamma subunits of the initiation factor complex eIF-4F.

Authors:  S J Morley; V M Pain
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

10.  Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E.

Authors:  S Pyronnet; H Imataka; A C Gingras; R Fukunaga; T Hunter; N Sonenberg
Journal:  EMBO J       Date:  1999-01-04       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.